Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hy...(ements whether as a result of new inform...),Health
Navigation Links
Endo Pharmaceuticals Gives Update on Regulatory Status of Testosterone Undecanoate for Men with Hypogonadism
Date:9/2/2009
ements, whether as a result of new information, future developments or otherwise.
'/>"/>
| SOURCE Endo Pharmaceuticals Copyright©2009 PR Newswire. All rights reserved |
Related medicine news :
1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
3. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
4. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
5. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
6. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
7. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
8. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
9. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
10. Provectus Pharmaceuticals, Inc. releases summary results of phase 1 metastatic melanoma study
11. Class Settlement Could Result in Considerable Savings for Certain Consumers of Prescription Pharmaceuticals
Post Your Comments:
(Date:12/4/2009)...e-USNewswire/ -- The American Association of Homes...enate for ensuring that the Community Living and ...he final health reform legislation . The CLASS pro...ers, people with disabilities and their caregivers...reform bill that will make it affordable to care f...
(Date:12/4/2009)...wire-USNewswire/ -- While Congress debates whether...s, Leapfrog,s purchaser members point to 45 hospit...st quality care in the nation while attaining the ...ight children,s and three rural hospitals have bee...lts from The Leapfrog Hospital Survey. ,, (Log...
(Date:12/4/2009)...chers, from the School of Medicine,s Department of...by which products of lipid peroxidation and some d...lized. The pathways were identified by a combinati...he findings shed new light on the mechanism of act...so known as "the date rape drug." The manuscript p...
(Date:12/4/2009)...nsumption leads to success, study finds , ... exercise, reduced soda consumption and self-weigh...rategies for adolescents, a new study shows. , ...eight-control strategies and lifestyle habits. Six...ot. The responses were grouped into four categorie...
(Date:12/4/2009)...ring winter isn,t known, CDC says, , , ...tates reporting widespread swine flu activity cont... 48 just two weeks ago, a U.S. health official sai... flu vaccine continues to increase, Dr. Thomas R. ...Control and Prevention, said during an afternoon p...
Breaking Medicine News(10 mins):Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 2Health News:The Leapfrog Group Releases Its 2009 Top Hospitals List 3Health News:Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week' 2Health News:Teens Lose More Weight Using Healthy Strategies 2Health News:Swine Flu Continues to Wane 2[0] Statement from AAHSA CEO Larry Minnix on the Failure of the Thune Amendment[0] The Leapfrog Group Releases Its 2009 Top Hospitals List[0] Case Western Reserve researchers' new pathway discovery published as 'Paper of the Week'[0] Teens Lose More Weight Using Healthy Strategies[0] Swine Flu Continues to Wane
... Researchers have identified a gene that contr...e stem cells that produce all blood cell types -- ... more streamlined treatments for leukemia and othe...ne that controls the rapid production and differen...
...RNewswire-FirstCall/ - IMRIS Inc. (TSX: IM) ("IMRI... international conference on intra-operative MR he.... Over 300 neurosurgeons from China, USA, Germany,...ir Chen Xiaohong, Director of PLA 301, and feature...
...National Hospice Leadership Conference on April 24...il 8, J. Donald Schumacher, NHPCO president and CE...House led by Nancy-Ann Min DeParle, the recently a...ator of the commitment of the administration to in...
...y & AJ,s grocery stores sell limited-edition, ...,s Hospital , , PHOENIX, April 8 Dodge the age-o...euse. It will help preserve Arizona and support Ph...haritable "green" mission this spring. The team of...
...study shows that an experimental drug lowers prost...mor growth in men with advanced prostate cancer f... The study, led by researchers at Memorial Sloan-K...ate cancer eventually build up resistance to the d...
...Renowned Translational Cancer Researchers and Upda... Academic and Industry Leaders , , NEW YORK, Apri... will discuss the rapidly changing cancer research... Clinical Investigator Symposium. , , The April 2...
Other Medicine News:Health News:Scientists Identify Key Gene That Protects Against Leukemia 2Health News:Scientists Identify Key Gene That Protects Against Leukemia 3Health News:Scientists Identify Key Gene That Protects Against Leukemia 4Health News:Neurosurgeons from around the world gather at PLA 301 Hospital in China 2Health News:NHPCO President/CEO Meets with Nancy-Ann Min DeParle at White House 2Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 2Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 3Health News:Hometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' Lifestyle 4Health News:Drug shows activity in men with advanced prostate cancer 2Health News:Drug shows activity in men with advanced prostate cancer 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 2Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 3Health News:Top Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium 4Scientists Identify Key Gene That Protects Against Leukemia Neurosurgeons from around the world gather at PLA 301 Hospital in ChinaNHPCO President/CEO Meets with Nancy-Ann Min DeParle at White HouseHometown Grocer, Local Food Companies Team up to Support Pediatric Patients, Encourage 'Green' LifestyleDrug shows activity in men with advanced prostate cancerTop Physician-Scientists Discuss State of Cancer Research at Damon Runyon Cancer Research Foundation Symposium
(Date:12/4/2009)... Dec. 4 PharmAthene, Inc...ing medical countermeasures against biological and...y is presenting results of a study demonstrating t...n anthrax model in the New Zealand White (NZW) rab...session at the HHS Public Health Emergency Medical...
(Date:12/4/2009)... Mass., Dec. 4 Axsun Tec...ano Corporation (Nasdaq: VOLC ), today announced ...a novel integrated light source architecture for O...al engine design raises the bar on imaging speed a...d designs for swept source OCT light sources. Thi...
(Date:12/4/2009)...N.J., Dec. 4 Watson Phar... specialty pharmaceutical company, today confirmed...orida, filed an Abbreviated New Drug Application (...eeking approval to market its 8mg ramelteon tablet...eda Pharmaceutical Company Limited. Watson,s 8mg ...
Breaking Medicine Technology:PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 2PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 3PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 4PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 5PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop 6Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 2Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 3Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 4Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging 5Watson Files FDA Application for Generic Rozerem(R) 2Watson Files FDA Application for Generic Rozerem(R) 3GeoVax Labs Inc Provides Third Quarter 2009 Financial Results and Operational Update 6044 1GeoVax Labs Inc Provides Third Quarter 2009 Financial Results and Operational Update 6044 2GeoVax Labs Inc Provides Third Quarter 2009 Financial Results and Operational Update 6044 3GeoVax Labs Inc Provides Third Quarter 2009 Financial Results and Operational Update 6044 4GeoVax Labs Inc Provides Third Quarter 2009 Financial Results and Operational Update 6044 5GeoVax Labs Inc Provides Third Quarter 2009 Financial Results and Operational Update 6044 6GeoVax Labs Inc Provides Third Quarter 2009 Financial Results and Operational Update 6044 7GeoVax Labs Inc Provides Third Quarter 2009 Financial Results and Operational Update 6044 8Caraco Pharmaceutical Laboratories Ltd Markets Generic Acular 28R 29 Opthalmic Solution 6042 1Caraco Pharmaceutical Laboratories Ltd Markets Generic Acular 28R 29 Opthalmic Solution 6042 2Early Morning Colonoscopies May Find More Polyps 60822 1Early Morning Colonoscopies May Find More Polyps 60822 2[0] PharmAthene Presents Animal Model Data for Valortim(R) at the 2009 BARDA Industry Conference / PHEMCE Stakeholders Workshop[0] Axsun Technologies, A Wholly-Owned Subsidiary of Volcano Corporation, Announces Breakthrough Integrated Light Source Architecture for Optical Coherence Tomography (OCT) Imaging[0] Watson Files FDA Application for Generic Rozerem(R)
...ut HIV and AIDS for Women, ATLANTA, Nov. 27 The ... change the course of the AIDS pandemic through a,...two prestigious business,awards for their Web port...Stevie(R) Award for Women in Business for Best Web...rld 100 Award in the health care category., "We a...
...ll lung, prostate and colore..., Nov. 27 Poniard,Pharmaceuticals, Inc. (Nasdaq: ...cology, today provided an update of its picoplatin...LC), colorectal cancer (CRC) and hormone,refractor... in solid,tumors. Presenting at the Lazard Capital...
Other Medicine Technology:The Well Project Web Portal Receives Stevie(R) Website of the Year, InfoWorld 100 Award 2The Well Project Web Portal Receives Stevie(R) Website of the Year, InfoWorld 100 Award 3The Well Project Web Portal Receives Stevie(R) Website of the Year, InfoWorld 100 Award 4Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference 2Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference 3Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference 4Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |